Drugs / Beta-hCG
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT05483621 | Mar 2021 → Feb 2022 | azoospermia | Egymedicalpedia | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00362414 | Aug 2006 → Mar 2008 | stroke disorder | University of California, Irvine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Beta HCG | “Administration of hormonal therapy (as Beta HCG (5000 IU I.M) twice weekly for three months” NCT05483621 ↗ |
| Known as | hCG | “This therapy will consist of hCG (3 once-daily IM doses at 10,000 IU per dose, one day apart, on days 1, 3 and 5 of study participation), followed by a one day washout period...” NCT00362414 ↗ |
| Route | Intramuscular | “hCG (3 once-daily IM doses at 10,000 IU per dose, one day apart, on days 1, 3 and 5 of study participation)” NCT00362414 ↗ |